30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Martin Samuel Bates

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Martin Samuel Bates's trades of Celldex Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-14
S Sale
99,264 +21.8%
123.86
US$571,981 		99,264 +21.8% 123.86 US$571,981
2024-06-14 2024-06-14
PrS Proposed sale
22,767
313.11
US$4,285,800 		22,767 313.11 US$4,285,800
2024-06-03 2024-05-30
S Sale
3,350 +4.0%
221.00
US$582,887 		3,350 +4.0% 221.00 US$582,887
2024-05-30 2024-05-30
PrS Proposed sale
35,000
34.05
US$1,191,771 		35,000 34.05 US$1,191,771
2022-08-15 2022-08-12
S Sale
1,221 -4.8%
34.62
US$42,272 		1,221 -4.8% 34.62 US$42,272
2022-08-15 2022-08-12
S Sale
2,065 -7.5%
35.38
US$73,053 		2,065 -7.5% 35.38 US$73,053
2022-08-15 2022-08-12
S Sale
14,261 -34.0%
36.76
US$524,304 		14,261 -34.0% 36.76 US$524,304
2022-08-15 2022-08-11
S Sale
2,453 -9.1%
37.04
US$90,856 		2,453 -9.1% 37.04 US$90,856
2021-11-17 2021-11-15
PlS Planned sale
2,048 -7.1%
42.27
US$86,569 		2,048 -7.1% 42.27 US$86,569
2021-11-17 2021-11-15
PlS Planned sale
7,452 -20.5%
43.92
US$327,314 		7,452 -20.5% 43.92 US$327,314
2020-06-10 2020-06-09
PP Planned purchase
9,750 +989.8%
3.05
US$29,738 		9,750 +989.8% 3.05 US$29,738